Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized studyShishu Zhu, Pan Zhao, Hongfei Zhang et al.|Journal of Hepatology|2018Cited by 85
Long‐term benefits of interferon‐α therapy in children with HBeAg‐positive immune‐active chronic hepatitis BLimin Wang, Fu‐Sheng Wang, Jinfang Zhao et al.|Journal of Viral Hepatitis|2021Cited by 21
Clinical Associations of Thyroid Hormone Levels with the Risk of Atherosclerosis in Euthyroid Type 2 Diabetic Patients in Central ChinaLimin Wang, Zhigang Zhao, Tingting Chen et al.|International Journal of Endocrinology|2020Cited by 15
Interferon-α plus ribavirin yields 98 % sustained virologic response in children aged 1–5 years with iatrogenic chronic hepatitis CShishu Zhu, Fu‐Sheng Wang, Qing‐Lei Zeng et al.|Hepatology International|2015Cited by 9
[A randomized controlled study on factors influencing the curative effect of sequential combined interferon and lamivudine therapy in children with immune-tolerant phase chronic hepatitis B].Shishu Zhu, Pan Zhao, Yi Dong et al.|PubMed|2019Cited by 7